|
|
 |
|
ROXITICUS
ADVISOR -
Howard Weisman
Howard Weisman
Advisor
Howard Weisman is President, Chief Operating Officer and
Director of ESP Pharma, a specialty pharmaceutical
company. Prior to founding ESP Pharma, Mr. Weisman began
his career at Merck & Co, Inc. and held several
positions of increasing responsibility in hospital sales
and marketing management for Merck's hospital product
line. Mr. Weisman joined Parke-Davis in 1994 as Director
of New Products and later was Senior Director, Diabetes
Marketing where he oversaw the launch of Rezulin in
1997. He went on to become the Senior Director of
Strategic Partnership Development at Parke-Davis and
co-founded the company’s E-Business Unit in 1999. Mr.
Weisman is a partner at ESP Partners LLC, a healthcare
consulting and investment firm, which he founded in
2000.
Mr. Weisman holds a BA in Chemistry from Rutgers
University and attended Princeton University Graduate
School of Chemistry.
|
|
|
 |
|
“You
cannot change your destination overnight, but you can
change your direction overnight” |
|
